肥胖是致命阿片类毒性的一个因素吗?
Jeremy W S Hunter1, Corinna Van Den Heuvel1, Lilli Stephenson1
1From the School of Biomedicine, The University of Adelaide, Adelaide, South Australia, Australia.
The American journal of forensic medicine and pathology
|March 4, 2025
概括
肥胖不会增加对致命阿片类药物毒性的敏感性. 这项研究发现,高体重指数 (BMI) 与高剂量死亡中较低的致命血片水平之间没有联系.
科学领域:
- 法医毒理学 法医毒理学
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
背景情况:
- 全球肥胖和阿片类药物滥用的增加带来了重大的公共卫生挑战.
- 与这两种情况相关的呼吸系统损害引发了对潜在协同效应的担忧.
研究的目的:
- 调查肥胖是否会增加对致命阿片类药物毒性的敏感性.
- 为了确定身体质量指数 (BMI) 较高的个体在较低的死后阿片类药物水平下是否会经历致命影响.
主要方法:
- 259个海洛因或吗啡毒性死亡病例 (2000-2019) 的回顾性审查来自法医科学SA.
- 分析与身体质量指数 (BMI) 分类 (肥胖和严重肥胖) 相关的死后药物水平.
- 使用费舍尔精确测试进行统计分析,以评估BMI和阿片类药物水平之间的关联.
主要成果:
- 平均BMI为26.8,其中有50名肥胖者 (BMI 30-39.9) 和17名致病肥胖者 (BMI ≥40).
- 在肥胖或致病性肥胖与死后阿片类药物水平之间没有发现显著的关联.
- 0.30的P值表明BMI和致命药物度之间没有统计学上显著的联系.
结论:
- 缺乏关联表明,增加的BMI不会增加对致命阿片类药物毒性的易感性.
- 肥胖的未确定的代谢或药物动力学因素可能会补偿阿片类药物的呼吸抑制作用.
- 需要进一步的研究来阐明这些补偿机制.
相关概念视频
Obesity
296
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
296
Opioid Analgesics: Morphine and Other Natural Cogeners
133
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
133
Opioid Analgesics: Synthetic and Semisynthetic Opioids
167
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
167
Analgesia and Pain Management
392
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
392
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
125
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
125
Opioid Receptors: Overview
307
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
307


